To determine whether the increase in glucose uptake following AMP-activated protein kinase (AMPK) activation in adipocytes is mediated by accelerated GLUT4 translocation into plasma membrane, we constructed a chimera between GLUT4 and enhanced green fluorescent protein (GLUT4-eGFP) and transferred its cDNA into the nucleus of 3T3-L1 adipocytes. Then, the dynamics of GLUT4-eGFP translocation were visualized in living cells by means of laser scanning confocal microscopy. It was revealed that the stimulation with 5-aminoimidazole-4-carboxamide-1-␤-D-ribofuranoside (AICAR) and 2,4-dinitrophenol (DNP), known activators of AMPK, promptly accelerates its translocation within 4 min, as was found in the case of insulin stimulation. The insulin-induced GLUT4 translocation was markedly inhibited after addition of wortmannin (P Ͻ 0.01). However, the GLUT4 translocation through AMPK activators AICAR and DNP was not affected by wortmannin. Insulin-and AMPKactivated translocation of GLUT4 was not inhibited by SB-203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK). Glucose uptake was significantly increased after addition of AMPK activators AICAR and DNP (P Ͻ 0.05). AMPK-and insulin-stimulated glucose uptake were similarly suppressed by wortmannin (P Ͻ 0.05-0.01). In addition, SB-203580 also significantly prevented the enhancement of glucose uptake induced by AMPK and insulin (P Ͻ 0.05). These results suggest that AMPK-activated GLUT4 translocation in 3T3-L1 adipocytes is mediated through the insulin-signaling pathway distal to the site of activated phosphatidylinositol 3-kinase or through a signaling system distinct from that activated by insulin. On the other hand, the increase of glucose uptake dependent on AMPK activators AICAR and DNP would be additionally due to enhancement of the intrinsic activity in translocated GLUT4 protein, possibly through a p38 MAPK-dependent mechanism.
IT HAS BEEN ESTABLISHED that insulin-stimulated glucose uptake into adipocytes and skeletal myocytes involves the translocation of GLUT4 from an intracellular pool to the plasma membrane. The intracellular mechanism for the recruitment of GLUT4-containing vesicle into plasma membrane has been investigated, and it has been revealed that phosphatidylinositol 3-kinase (PI3K) plays a crucial role in insulin-stimulated GLUT4 translocation (7, 14, 24) . However, little has been elucidated concerning other mechanisms to enhance the GLUT4 translocation than the insulin signaling system. AMP-activated protein kinases (AMPKs) have been known to act as a metabolic sensor in mammalian cells (9, 30) . The kinase activity is enhanced by a relative increase in cellular AMP level (increase in AMP-to-ATP ratio) through a metabolic uncoupler, dinitrophenol (DNP), to decrease ATP concentration and by 5-aminoimidazole-4-carboxamide-1-␤-D-ribofuranoside (AICAR), an adenosine analog. After entering into cells, AICAR is phosphorylated, and the reaction product 5-aminoimidazole-4-carboxamide ribonucleotide mimics the action of AMP to activate AMPK (6, 19) . In the case of skeletal myocytes, activation of AMPK through physiological stimulation such as muscle contraction or by the pharmacological activator AICAR leads to a significant increase of glucose uptake mediated by the translocation of GLUT4 (10, 20) .
It has been reported that GLUT4 translocation is accelerated by stimulation other than by insulin, such as hyperosmolar shock and bradykinin (2, 4, 15) , but the precise mechanism has not yet been elucidated. In addition, although AMPK activation by AICAR in adipocytes has also been observed to increase glucose uptake under basal conditions (27) , it seems to be still unclear whether or not its increase is mediated by GLUT4 translocation. In this study, we monitored in real time the GLUT4 trafficking in living, single 3T3-L1 adipocytes by use of a chimera between GLUT4 and the intrinsically fluorescent enhanced green fluorescent protein (eGFP). The time-dependent acceleration of GLUT4 translocation was measured using laser-scanning confocal microscopy after AMPK activation by AICAR and DNP. The effect of insulin was examined in parallel for a comparative purpose. The involvement of PI3K and p38 mitogen-activated protein kinase (MAPK) activation was also investigated in the mechanisms for accelerated GLUT4 translocation and increased glucose uptake through AMPK activation in 3T3-L1 adipocytes.
MATERIALS AND METHODS
Materials. Wortmannin, AICAR, and bovine serum albumin (BSA) were from Sigma (St. Louis, MO), and DNP and 2-deoxy-D-glucose (2-DG) were from Wako (Osaka, Japan). SB-203850 was from Calbiochem (La Jolla, CA). 2-[ Preparation of cells. 3T3-L1 cells were obtained from the cell bank of Japanese Collection of Research Bioresouces (Tokyo, Japan). Cells were seeded and fed every 2-3 days in Dulbecco's modified Eagle's medium (DMEM) high glucose supplemented with 50 U/ml penicillin, 50 g/ml streptomycin, 100 mM MEM sodium pyruvate, and 10% fetal calf serum and were grown under 5% CO 2 at 37°C. At confluence, differentiation was started by addition of medium containing 500 M isobutylmethylxanthine (IBMX, Sigma), 250 M dexamethasone (Sigma), and 1.7 M insulin. After 48 h, this mixture was replaced with fresh medium. Between days 7 and 10 after induction of differentiation, the glucose uptake was determined using 2-[ 14 C]DG, and the dynamics of GLUT4 translocation were monitored in living cells by transferring the cDNA of GLUT4-eGFP into their nucleus.
Cell microinjection of GLUT4-eGFP cDNA. 3T3-L1 adipocytes were injected with cDNA of GLUT4-eGFP using an Eppendorf microinjector system (Femtojet; Eppendorf, Hamburg, Germany) fit- Fig. 1 . Visualization of GLUT4 translocation using GLUT4-eGFP (enhanced green fluorescent protein) chimeric protein and dynamics of its intracellular distribution after addition of stimulants. Each image was obtained using laser-scanning confocal microscopy before (1), and 4 (2), 10 (3), and 20 min (4) Image capture of GLUT4 translocation and its analysis. The transfected 3T3-L1 adipocytes with GLUT4-eGFP were imaged with a laser-scanning confocal microscope LSM 510 (Carl Zeiss, Jena, Germany) to monitor the dynamics of GLUT4 translocation. Transfected cells were on a heated stage adjusted to provide a temperature of 37°C in the bathing KRB buffer. Images were collected using 488-nm excitation wavelength every 1 min. The eGFP signals were analyzed with NIH Image software (version 1.61, National Institute of Mental Health, NIMH Public Inquiries, Bethesda, MD). To quantify the extent of GLUT4-eGFP translocation to the plasma membrane, the ratio of fluorescence intensity in the peripheral region to that in the remaining cellular fluorescence was calculated. The peripheral-tocellular ratio in the basal state was expressed as 100(%), and the area under the curve during the 20-min stimulation was calculated for the quantitative comparison.
2-DG uptake assay. The differentiated 3T3-L1 adipocytes were serum starved using serum-free Hanks' buffer (pH 7.4) prior to glucose uptake experiments, as described above, and were preincubated for 140 min. For 2-DG uptake measurements, 0.2 Ci 2-[ 14 C]DG was then added to the medium containing 1 mM nonra-
dioactive 2-DG. After the incubation for 20 min at room temperature along with each stimulant (insulin, DNP, or AICAR), glucose uptake was stopped by aspiration of the buffer. Cells were rapidly washed several times with 1 ml of ice-cold phosphate-buffered saline and solubilized by the addition of 0.2 M NaOH. Nonspecific uptake was determined in parallel in the presence of 10 M cytochalasin B. The radioactivity associated with the cells was measured using a scintillation counter (LSC-3100; Aloca, Tokyo, Japan), as has been described previously (21) . Statistical analysis. Statistical analysis was performed by analysis of variance using StatView computer software (Abacus, Berkeley, CA). Results are expressed as means Ϯ SE, and P Ͻ 0.05 was considered significant.
RESULTS

Visualization of GLUT4 translocation and its dynamics of intracellular distribution.
The dynamics of GLUT4-eGFP translocation were visualized and monitored using laser-scanning confocal microscopy. Each image in Fig. 1 indicates the intracellular localization of GLUT4 before (1), and 4 (2), 10 (3), and 20 min (4) after the addition of 10 Ϫ7 M insulin, 10 Ϫ4 MDNP, or 10 Ϫ3 M AICAR. As indicated in Fig. 1A , insulin stimulation elicited GLUT4 translocation into plasma membrane within 4 min. On the other hand, the time-dependent translocation was almost diminished by the pretreatment with 3 ϫ 10 Ϫ8 M wortmannin (Fig. 1B) . Administration of DNP or AICAR alone similarly promoted GLUT4 translocation within 4 min in a time-dependent manner (Fig. 1, D and G) . The pretreatment with wortmannin, however, failed to inhibit the translocation by DNP or AICAR (Fig. 1, E and  H) . In addition, the translocation induced by insulin, DNP, or AICAR was not affected by the pretreatment with 10 Ϫ5 M SB-203580. (Fig. 1, C, F, and I) .
Quantitative assessment of GLUT4 translocation by each stimulant. A significant increase in the peripheral/cellular ratio of GLUT4-eGFP fluorescence intensity was observed 4 min after the addition of insulin (138.2 Ϯ 13.3% of the basal state, P Ͻ 0.05), and it consistently continued thereafter (P Ͻ 0.05; Fig. 2A ). When the cells were pretreated with wortmannin, however, no apparent acceleration of the GLUT4 translocation was found, and the statistically significant suppression was noted in the translocation during the insulin stimulation (P Ͻ 0.05; Fig. 2A ). DNP and AICAR also significantly enhanced the GLUT4 translocation 4 min after the addition (140 Ϯ 10.5 and 130.7 Ϯ 8.5% of the basal state in DNP and AICAR stimulation, respectively, P Ͻ 0.05; Fig.  2, B and C) . In contrast, the wortmannin pretreatment failed to suppress the GLUT4 translocation stimulated with DNP or AICAR (Fig. 2, B and C) . The addition of SB-203580 did not suppress the translocation by insulin, DNP or AICAR (Fig. 2,  A-C) . When the area under the curve of peripheral/cellular ratio of fluorescence intensity was calculated (Fig. 3A) , it was confirmed that wortmannin could almost completely inhibit the insulininduced GLUT4 translocation (63,081 Ϯ 8,516 and 181 Ϯ 844 arbitary units in insulin alone and insulin plus wortmannin, respectively, P Ͻ 0.01), but not by DNP or AICAR (Fig. 3, B and  C) . No significant effect on the accelerated translocation by insulin, DNP, or AICAR was observed by the addition of SB-203580 (Fig. 3, A-C) .
Insulin-, DNP-, and AICAR-induced 2-DG uptake inhibition by wortmannin or SB-203580.
The stimulation by insulin, DNP, and AICAR enhanced 2-DG uptake 2.8 Ϯ 0.14-, 2.4 Ϯ 0.21-, and 1.7 Ϯ 0.14-fold, respectively (P Ͻ 0.01). The addition of wortmannin did not affect the basal 2-DG uptake but markedly suppressed the insulin-induced glucose uptake (5,215 Ϯ 429 and 1,618 Ϯ 277 cpm/10 6 cells in insulin alone and insulin plus wortmannin, respectively, P Ͻ 0.01). Inter- 
DISCUSSION
Through the monitoring system of visualized GLUT4-eGFP translocation (22, 25) , we have demonstrated here that the stimulation with DNP and AICAR, known activators of AMPK, promptly promotes the GLUT4 translocation within 4 min, as has been previously reported in the case of insulin (13, 16, 23) . In addition, the translocation induced by DNP and AICAR was not affected by wortmannin, suggesting that AMPK-stimulated GLUT4 translocation in 3T3-L1 adipocytes is mediated through the insulin-signaling pathway distal to the site of activated PI3K or through a signaling system distinct from that of insulin. This finding seems to be consistent with the case of enhanced GLUT4 translocation in skeletal muscles, in which AMPK activity has reportedly been elevated through their contraction (11, 17) . Because the GLUT4 translocation induced by insulin stimulation and AMPK activation in 3T3-L1 adipocytes was not found to be affected by SB-203580, a known inhibitor of p38 MAPK, the recruitment of GLUT4 to the plasma membrane was unlikely to have been mediated by p38 MAPK signaling.
The addition of AMPK activators AICAR and DNP enhanced glucose uptake in 3T3-L1 adipocytes, as was found in the case of insulin stimulation. In contrast to the case of GLUT4 translocation, however, the glucose transport activity was significantly reduced by the addition of wortmannin. It has been supposed that the magnitude of glucose transport after insulin stimulation is regulated by promoting the GLUT4 translocation via PI3K activation (7, 14, 24) and also through increasing the intrinsic transport activity of GLUT4 by protein phosphorylation via p38 MAPK activation (3, 28, 29) . Although wortmannin has been used as an inhibitor of PI3K, this agent has been additionally reported to inhibit insulin-dependent p38␣ and p38␤ MAPK activities with an IC 50 of 6 ϫ 10
Ϫ9
M and 2 ϫ 10 Ϫ9 M, respectively (28) . Because the concentration of wortmannin used in this experiment was 3 ϫ 10 Ϫ8 M, it can be expected that it suppresses the p38 MAPK activities in 3T3-L1 adipocytes. In fact, the AMPK-activated glucose transport activity was found to be significantly suppressed by SB-203580 in the present study. Because the magnitude of the 2-DG transport response by insulin and AMPK activators was found to be relatively poor compared with that in previous studies (3, 29) , the degree of cell differentiation of 3T3-L1 adipocytes might have been lower in our cell preparations. However, the significance in the reduction of glucose uptake by the addition of wortmannin and SB-203580 could still be valid, because apparent GLUT4 translocation into the plasma membrane of 3T3-L1 adipocytes was observed in the cell preparations similar to those in the glucose uptake assay. It could, accordingly, be speculated that the enhancement of glucose transport induced by AMPK activation in 3T3-L1 adipocytes is mediated by the increase of intrinsic activity through p38 MAPK activation of translocated GLUT4 protein, as has been suggested in the case of skeletal muscle (18) . A detailed evaluation would be needed in the future regarding which isoforms of p38␣ and p38␤ MAPK can be phosphorylated and activated during this process. However, because it has been demonstrated that SB-203580 inhibited the nucleotide transport system and therefore can indirectly reduce AICARstimulated AMPK activity (8) , further examinations should be carefully conducted on the exact role of AMPK and p38 MAPK activation in the accelerated glucose uptake activity of GLUT4 protein in 3T3-L1 adipocytes. It has been recently reported that AICAR-stimulated glucose transport was dependent on activation of the extracellular signal-regulated kinase pathway, phospholipase D, and atypical protein kinase C isoforms in myocytes (5) . Interestingly, the possible involvement of AMPK-independent signaling has been also proposed, using the system of overexpression of a dominant negative AMPK mutant (26) . It should be an interesting issue to be resolved, therefore, how AMPK-dependent and -independent pathways are related to the AICAR-induced glucose uptake observed in 3T3-L1 adipocytes. On the other hand, in adipose cells including 3T3-L1, it has been observed that GLUT1, another isoform of glucose transporters, is also functionally expressed (12) . AICAR has been reported to increase the intrinsic activity of GLUT1 protein via activated p38 MAPK to enhance the glucose transport into Clone 9 cells, a rat liver-derived, nontransformed cell line that expresses only the GLUT1 (1, 31) . The increased intrinsic activity of GLUT1 as well as GLUT4 could potentially induce the enhancement of glucose uptake after AMPK activation in 3T3-L1 adipocytes. In contrast to our findings, Salt et al. (27) have demonstrated that AICAR does not significantly enhance the translocation of GLUT4 or GLUT1 to the plasma membrane, whereas a modest stimulation of glucose uptake was simultaneously observed. The precise reason for the discrepancy in the translocation of GLUT4 between their results and ours is still unclear at present, but the effect on 3T3-L1 cells might have been too small in their experiments to be detected by the plasma membrane lawn assay, because their method is supposedly less sensitive for the detection compared with ours using the system of the GLUT 4-e GFP chimeric protein. Further studies concerning the intracellular system for translocation and activation of various GLUT isoforms are necessary to clarify this issue.
In the present study, it is revealed that AMPK activators AICAR and DNP can accelerate GLUT4 translocation in 3T3-L1 adipocytes, as has been observed in skeletal muscles. The mode of action on the translocation through AMPK activation was as quick, within 4 min, as in the case of insulin stimulation, but it was shown to be mediated by a signaling system distal to the PI3K activation through insulin stimulation or by a pathway distinct from that activated by insulin. On the other hand, the enhancement of glucose uptake was further mediated by the increased intrinsic activity of GLUT4 protein, possibly through p38 MAPK activation. The activation of AMPK in adipocytes would be a new therapeutic target for the glycemic control of type 2 diabetes.
